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Polarized Th1 and Th2 cells are less responsive to negative
feedback by receptors coupled to the AC/cAMP system compared
to freshly isolated T cells
1,2Irene H. Heijink, 2Edo Vellenga, 3Peter Borger, 4Dirkje S. Postma, 1Jan G.R.de Monchy &
*,1Henk F. Kauffman
1Department of Allergology, University Hospital Groningen, Groningen, The Netherlands; 2Department of Hematology,
University Hospital Groningen, Groningen, The Netherlands; 3Institute of Respiratory Medicine, University of Sydney, Australia
and 4Department of Pulmonology, University Hospital Groningen, Groningen, The Netherlands
1 The adenylyl cyclase (AC)/cyclic adenosine monophosphate (cAMP) system is known to
negatively regulate transcriptional activity of T cells, thereby possibly modulating T-cell-mediated
responses at the sites of inflammation. Effects of cAMP have been widely studied in freshly isolated T
cells and T-cell clones; yet, effects in differentiated Th1 and Th2 cells are largely unknown.
2 To obtain differentiated T helper cells, we activated naive T cells for 1 week in the presence of IL-
12 plus a-IL-4 to generate Th1-type cells and in the presence of IL-4 plus a-IL-12 to generate Th2-type
cells.
3 We demonstrate that, in contrast to freshly isolated T cells, the production of Th1 (IFN-g) and Th2
(IL-4, IL-5) cytokines in polarized T helper cells is not strictly controlled by the activation of AC/
cAMP-linked b2-adrenergic and prostaglandin (PG)E2 receptors.
4 In Th2 cells, PGE2 could still activate the Gs protein-coupled AC/cAMP system and subsequently
induce CREB phosphorylation, whereas PGE2 was unable to activate the cAMP-dependent pathway
in Th1 cells. In both Th1 and Th2 cells, the induction of CREB phosphorylation by b2-agonist
fenoterol was impaired.
5 The loss of control over cytokine production by cAMP elevating agents in differentiated Th1 and
Th2 subsets may have important implications for the regulation of Th1- and Th2-mediated diseases, in
particular those associated with the ongoing immune responses.
British Journal of Pharmacology (2003) 138, 1441 – 1450. doi:10.1038/sj.bjp.0705193
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Abbreviations: AC, adenylyl cyclase; b2AR, b2-adrenergic receptor; bARK, b-adrenergic receptor kinase; b2mG, b2-micro-
globulin; cAMP, cyclic adenosine monophosphate; CRE, cAMP responsive element; CREB, cAMP-responsive
element binding protein; db, dibutyryl; GRK, G protein-coupled receptor kinase; IBMX, 1-methyl-3-
isobutylxantine; JNK, c-Jun N-terminal kinase; MAP, mitogen activated protein; PDE, phosphodiesterase;
PGE2, prostaglandin E2; PI3-kinase, phosphatidylinositol 3-kinase; PKA, protein kinase A; PKC, protein kinase
C; Th, T helper
Introduction
The cyclic adenosine monophosphate (cAMP)-dependent
pathway is an important negative feedback system in the
regulation of inflammatory activity. Expression of cytokine
production in T lymphocytes is regulated by prostaglandin
(PG)E2 and b2-agonists, which activate receptors coupled to
the cAMP-dependent pathway. Upon receptor binding, the
associated Gs protein triggers adenylyl cyclase (AC) activity,
resulting in the formation of intracellular cAMP. Cytokine
genes containing a cAMP-responsive element (CRE) in their
promoter, like the IFN-g gene, can be regulated by the protein
kinase A (PKA)-mediated phosphorylation of cAMP-respon-
sive element binding protein (CREB) (Nigg et al., 1985;
Gonzalez & Montminy, 1989; Masquilier & Sassone-Corsi,
1992). Not all cytokine genes that are controlled by the cAMP-
dependent pathway contain a CRE in their promoter. For
instance, no binding site for CREB has been found in the IL-5
promoter region. Expression of cytokine genes lacking this
binding site can be affected indirectly by cAMP, most likely by
the modulation of the signal transduction pathways, including
the mitogen activated protein (MAP) kinase pathways (Wu
et al., 1993; Tamir et al., 1996; Harada et al., 1999).
In T cells, cAMP elevating substances are known to dose-
dependently control the production of both Th1 and Th2
cytokines (Betz & Fox, 1991; Snijdewint et al., 1993; Hilkens
et al., 1995; Borger et al., 1996, 1998, 1999), although the
ultimate effect on Th2 cytokines appears to be dependent on
the activation state and costimulatory signals (Hilkens et al.,
1995; Borger et al., 1996, 1998). cAMP has been described to
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inhibit Th2 cytokine production in freshly isolated T cells
activated with CD3 plus CD28 antibodies (Borger et al., 1996),
whereas it slightly enhances the production of IL-5 in the
presence of potent PKC activators or high concentrations of
IL-2 (Borger et al., 1996, 1998) and strongly upregulates IL-5
in Th2 clones (Snijdewint et al., 1993; Lee et al., 1994). Since T-
cell clones may be dysregulated because of many cell divisions,
this effect in Th2 clones may not be representative for in vivo
conditions. Furthermore, the existence of strictly separated
Th1 and Th2 subsets in the human immune system has been
under discussion. However, polarized Th1 and Th2 cells may
exist at the sites of tissue inflammation; several immune
responses are associated with the presence of Th1 and Th2
subsets, including Th1-mediated autoimmune diseases and
Th2-mediated allergies (Abbas et al., 1996; O’Garra, 1998). At
the initiation of an immune response, autocrine IL-2 induces
the proliferation of naive helper cells. Subsequently, the
specific cytokine environment determines the final outcome
of the T helper subtype (Abbas et al., 1996; O’Garra et al.,
1998). From in vitro studies, it has become clear that naive
CD4+ cells differentiate into polarized Th1 and Th2 during
activation in the appropriate environment, for example, in the
presence of IL-12 (Hsieh et al., 1993; Seder et al., 1993) or IL-4
(Seder et al., 1992), respectively. In addition, when T cells are
only activated for a short period or in the absence of specific
cytokine environment, nonpolarized intermediates or Th0 cells
develop, which are able to produce various patterns of
cytokines. Recent studies have demonstrated that entering
the cell cycle is essential to induce epigenetic remodeling, that
is, alterations in chromatin structure, which is crucial for
differentiation towards a Th1 or Th2 phenotype and the
efficient production of the associated cytokines (Argawal &
Rao, 1998; Bird et al., 1998). The effects of cAMP have not
been examined thoroughly in polarized Th1 and Th2 subsets,
although this may provide insight into the regulation of Th1-
and Th2-associated immune responses. We investigated the
regulation of cytokine production by cAMP in Th1 and Th2
cells and demonstrate that control over cytokine production by
cAMP elevating agents operating via AC-coupled receptors is
partially lost in Th2 subsets and completely lost in Th1 subsets.
Experimental procedures
Isolation of T cells
Peripheral blood cells were obtained from healthy volunteer
platelet donors. Peripheral blood mononuclear cells (PBMC)
were isolated by Ficoll – Hypaque (Lymphoprep; Nycomed,
Oslo, Norway) density-gradient centrifugation. T cells were
isolated by rosetting with 2-aminoethylisothioronium bromide
(AET)-treated sheep red blood cells (SRBC). The SRBC were
lysed with 155mmol l1 NH4Cl, 10mmol l
1 KHCO3 and
0.1mmol l1 EDTA. After isolation, T cells were incubated
overnight at 371C in RPMI 1640 (BioWhittaker, Verviers,
Belgium) containing 5% fetal calf serum (FCS; Hyclone,
Logan, UT, U.S.A.), supplemented with 100Uml1 penicillin
and 100mgml1 streptomycin.
Th1/Th2 polarization
T lymphocytes were isolated from peripheral blood of healthy
volunteer platelet donors as described above. The T cells were
differentiated into Th1 and Th2 subsets as described before
(Roozendaal et al., 2001). In short, naive helper T lymphocytes
were sorted after staining with a-CD45RO-FITC (UHCL-1)
and a-CD4 CyQ (B-F5) (Immune Quality Products (IQP),
Groningen, The Netherlands using a MoFlowt Flow cyt-
ometer (Cytomation, Fort Collins, CO, U.S.A.) calibrated
using Flow-Checkt Fluorospheres (Beckman Coulter, Paris,
France). Purity was above 98% by reanalysis. Cells were
cultured in RPMI 1640 medium containing 10% FCS, in the
presence of PHA, IL-2, irradiated allogenic PBMC (neutral
conditions) and either IL-12 (2 ngml1, R&D systems, ITK
diagnostics, Uithoorn, The Netherlands) plus a-IL-4
(200 ngml1, Becton Dickinson, Erebodegem-Aalst, Belgium)
to generate polarized Th1 cells, or IL-4 (200Uml1, Becton
Dickinson) and a-IL-12 (2 mgml1, R&D systems) to generate
polarized Th2 cells. To confirm that Th1 and Th2 phenotypes
were obtained after 7 days, the cells were analyzed for
intracellular cytokines as described before (Jung et al., 1993).
In short, the polarized T helper cells were replated in RPMI
medium containing 5% FCS and cultured overnight. Next, the
cells were stimulated with PMA (10 ngml1) and ionomycin
(1 mgml1) for 4 h in the presence of monensin (2 mM, Alexis,
La¨ufelfingen, Switzerland). Cells were fixed in 4% parafor-
maldehyde, permeabilized in 0.1% saponin/0.1% azide and
stained using a-CD4-CyQ (B-F5, IQP, Groningen), a -IFN-g-
FITC (45-15, IQ P) and a-IL-4-PE (B-T4, CLB, Amsterdam,
The Netherlands). Irrelevant specificity antibodies of the same
isotype were used for gate setting. Analysis was performed
using an Elitet flow cytometer (Beckman Coulter). Lympho-
cyte events were gated on the basis of forward and sideward
scatter characteristics. The intracellular cytokine stainings
indicated that highly divergent cytokine production patterns
were obtained after 1 week of culture. Virtually all cells became
CD45RO+ after culturing under polarizing conditions. In the
cell population polarized under Th1 conditions, approximately
40% of the CD4+ cells was IFN-g+/IL-4 and 0.5% was IL-
4+/IFN-g, whereas in the cell population cultured under Th2
conditions, approximately 10% was IL-4+/IFN-g and 0.5%
was IL-4/IFN-g+. In both cell populations, only a small
percentage of the cells was positive for both cytokines.
Stimulation of the T cells
After 7 days of culture under polarizing conditions, the cells
were rested overnight in RPMI medium containing 5% FCS.
For stimulation, polarized T helper cells or freshly isolated T
cells (1 – 3 106ml1) were incubated in RPMI 1640 medium
containing 5% FCS with 50 ml ml1 of a-CD3 and a-CD28
antibodies, as previously described by Borger et al. (1999), in
the presence or absence of PGE2 (Sigma, St Louis, MO,
U.S.A.) in a final concentration of 10 (mM b2-agonist fenoterol
(Sigma) in a final concentration of 10 mM, cAMP analog
dibutyryl (db)-cAMP (Boehringer-Mannheim GmbH, Ger-
many) in a final concentration of 0.5 mM or phosphodiesterase
(PDE) inhibitor l-methyl-3-isobutylxantine (IBMX, Alexis,
La¨ufelfingen, Switzerland) in a final concentration of 100mM.
Measurement of cytokine protein
Polarized T cells or freshly isolated T cells (1 – 3 106ml1)
were left unstimulated or stimulated with a-CD3/a-CD28
during 6 – 8 h. Secreted IL-4, IL-5 and IFN-g proteins were
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measured in cell-free supernatants, using enzyme-linked
immunosorbent assay (ELISA) kits for IL-4 and IFN-g
(CLB). The IL-5 ELISA was performed as previously
described by Hoekstra et al. (1997).
Measurement of intracellular cAMP accumulation
After resting overnight, T lymphocytes (3 106ml1) were
suspended in RPMI 1640 medium. Stimulation of cAMP
production was performed as described before (Meurs et al.,
1980). In short, the samples were incubated with IBMX
(0.5mM) for 10min to prevent cAMP degradation. After
preincubation, the samples were stimulated for 10min with
PGE2 (10mM). Reactions were terminated by adding 2N HCl –
0.1M EDTA followed by incubating the samples at 801C for
10min. After centrifugation of precipitated protein, the
samples were neutralized by CaCO3 and cAMP was measured
using an enzyme immunoassay (Biotrak, Amersham, Buck-
inghamshire, U.K.) according to the manufacturer’s guide-
lines. cAMP concentrations are expressed as fmol cAMP/106T
lymphocytes.
Immunodetection by Western blotting
Phosphorylation of CREB and expression of G protein-
coupled receptor kinase 3 (GRK3/bARK2) were analyzed by
Western blotting. T cells (1 – 3 106) were cultured overnight
in 1 1/2ml RPMI 1640 medium containing 0.5% FCS. The
cells were incubated with PGE2 (10 mM), fenoterol (10 mM), db-
cAMP (0.5mM), IBMX (100 mM) or sodium fluoride (NaF,
Sigma, 10mM), to directly activate the G protein, in final a
concentration of 10mM for 60min to study CREB phosphor-
ylation, or left unstimulated to study bARK expression. T cells
were harvested and spun down at maximum speed during 30 s.
Next, total cell lysates were obtained by resuspension of the
pellets in 1 sample buffer (containing 2% SDS, 10%
glycerol, 2% b-mercaptoethanol, 60mM Tris-Cl pH 6.8 and
bromophenol blue) and boiling for 5min. Samples were loaded
on a SDS 10% PAGE gel (acrylamide : bisacrylamide 173 : 1)
and transferred to a cellulosenitrate membrane (Schleicher &
Schuell, Germany). Immunoblotting was performed by stan-
dard procedures and the detection was performed according
the manufacturer’s guidelines (ECL, Amersham). Relative
protein levels were quantified using the gelscan program
Diversity One (Pharmacia, Uppsala, Sweden).
Reverse transcription (RT) – polymerase chain reaction
(PCR)
Polarized T cells (5 106) were rested overnight in RPMI
medium containing 5% FCS, harvested and RNA was isolated
using the TRIzol method (GIBCOBRL, Burlington, Ontario,
Canada). Total cellular RNA was resuspended in diethyl-pyro-
carbonate (DEPC; Sigma) treated H2O. A volume of 1mg
RNA was used for cDNA synthesis. First, the samples were
incubated during 10min at 651C with a random hexamer (pdN6).
After cooling on ice, RT mix containing 5RT buffer
(GIBCOBRL), 0.1M DTT, 5mM of each dNTP and 3U of
Reverse Transcriptase (GIBCOBRL) was added and the samples
were incubated at 371C for 1h. For the PCR reaction, 10PCR
buffer (GIBCOBRL), 50mM of forward and reverse primer, 0.25ml
Taq polymerase, 2mM dNTP’s and 75ml MgCl2 in 25ml total
volume were added. The following specific primer pairs for b2
microglobuline (b2mG, housekeeping gene), EP2 (an AC-coupled
subtype of the PGE2 receptor), EP3 (a Gi-coupled subtype of the
PGE2 receptor) and b2-adrenergic receptor (b2AR) were obtained
from Biolegio BV (Malden, The Netherlands):
b2mG: 50CCAGCAGAGAATGGAAAGTC30 sense and
50GATGCTGCTTACATGTC TCG30 antisense. b2AR: 50CC
TTCTTGCTGGCACCCCAT30 sense and 50GGAAGTCCA
AAACTCGCACCA30 antisense. EP2: 50CCTCCTGAGAAA
GACAGTGCT30 sense and 50AAGACACTCTCTGAGTC
CT3 antisense. EP3: 5
0TGCTGGGCGTGGGCCGCTACA30
sense and 50GACCAACAGACGGACAGCACA30 antisense.
PCR conditions were a denaturation step at 941C for 5min
followed by 20 cycles of 941C, 30 s; 551C, 30 s; 721C, 30 s for
detection of b2mG, 35 cycles of 941C, 30 s; 581C, 30 s; 721C, 30 s
for detection of b2AR, 25 cycles of 941C, 30 s; 551C, 30 s; 721C,
30 s for detection of EP2 and 30 cycles of 941C, 30 s; 551C, 30 s;
721C, 30 s for detection of EP3. With these primers, the
amplified products were 268, 295, 395 and 300 bp long for
b2mG, b2AR, EP2 and EP3, respectively. After PCR, 10 ml of
the reaction mixture was run on a 1.5% agarose gel containing
0.2mg ethidium bromide in 1TAE buffer. A 100 bp ladder
(Pharmacia) was used as DNA marker. Relative mRNA levels
were quantified using the gelscan program Diversity One
(Pharmacia, Uppsala, Sweden).
Table 1 Absolute amounts of secreted cytokine protein in freshly isolated and polarized T cells
T cell type Treatment Cytokine secretion in pg ml1
IFN-g IL-4 IL-5
Freshly isolated Basal ND ND ND
a-CD3/a-CD28 353973037 15.3712.8 54.8747.5
+ PGE2 10mm 33.6739.2 5.373.8 4.573.1
+ fenoterol 10 mm 6797310 10.179.3 26.5723.9
Polarized Basal 4557347 0.470.1 14.2715.8
a-CD3/a-CD28 1021377803 84.4788.8 5067316
+ PGE2 10mm 1001874050 58.3737.8 4007241
+ fenoterol 10 mm 1020074020 79.4742.5 4997385
Freshly isolated T cells or polarized Th cells were left unstimulated or stimulated by a-CD3/a-CD28 in the presence and absence of 10mM
PGE2 or fenoterol for 6 – 8 h IFN-g protein was measured in supernatant from freshly isolated T cells and polarized Th1 cells. IL-4 and IL-
5 proteins were measured in supernatant from freshly isolated T cells and polarized Th2 cells. Results arc expressed as means7s.e.m.,
n=8. ND: not detectable.
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Statistical analysis
For the protein measurements, statistical analysis was per-
formed using a nonparametric test for paired observations
(Wilcoxon-signed ranks test). Statistical significance of the
secretion data was set at Po0.05.
Results
Control over cytokine production by cAMP elevating
agents in polarized helper T cells is reduced compared to
freshly isolated T cells
There was a wide range in the levels of cytokines secreted by
the different blood donors. Absolute values (mean7s.e.m.) of
cytokine secretion are given in Table 1. Since similar effects
were exerted by cAMP elevating agents in low and high
cytokine producers, cytokine protein levels are expressed as a
percentage of the cytokine secretion upon stimulation in the
absence of the cAMP elevating agents. As demonstrated in
Figure 1a, secretion of IFN-g was strongly inhibited by 10mM
PGE2 (from 100 to 473%, Po0.001, n¼ 8) and to a smaller
extent by 10 mM of short-acting b2-agonist fenoterol (from 100
to 20712%, Po0.001, n¼ 8) in freshly isolated, a-CD3/a-
CD28 stimulated T cells. The secretion of the Th2 cytokines
IL-4 and IL-5 was also under firm control of 10 mM PGE2 in
these cells (inhibition from 100 to 3279 and 15710%,
respectively, Po0.001). Fenoterol of 10mM moderately, but
significantly, reduced IL-4 and IL-5 secretion (from 100 to
71717 and 64720%, respectively, Po0.03, Figure 1a). Dose-
dependent effects of fenoterol and PGE2 on cytokine produc-
tion in stimulated freshly isolated T cells are depicted in
Figure 1b (n¼ 4). The secretion of IFN-g appeared to be more
sensitive to fenoterol and PGE2 compared to the secretion of
IL-5, whereas IFN-g production was still significantly inhib-
ited by 10 nm fenoterol and PGE2 (Po0.01). IL-5 was only
significantly inhibited when fenoterol and PGE2 were used in
higher concentrations (from 100 nm to 10 mM).
Interestingly, cytokine production appeared to be differently
regulated by cAMP elevating agents in polarized T helper cells.
In contrast to the strong inhibitory effects on IFN-g protein
secretion in freshly isolated T cells (Figure 1a), there was a
complete absence of control over IFN-g secretion by PGE2 and
fenoterol (10 mM) in polarized Th1 cells (Figure 1b). In
polarized Th2 cells, the control of IL-4 and IL-5 secretion
was also reduced compared to freshly isolated T cells. No
inhibitory effect was found upon stimulation of the b2-
adrenoceptor with fenoterol (10 mM). In contrast, the secretion
of IL-4 and IL-5 protein was still modestly, but significantly,
inhibited by 10mM PGE2 (from 100 to 62719 and 74710%,
Po0.05 and Po0.01, respectively). The loss of control in Th2
and Th1 subsets may be because of differential regulation of
the cytokine gene promoters or by impaired activation of the
cAMP-dependent pathway.
CREB phosphorylation induced by different cAMP
elevating agents
To investigate whether the cAMP-dependent pathway can still
be efficiently activated in polarized Th1 cells and Th2 cells, we
studied the phosphorylation of downstream effector CREB. In
Figure 1 (a) Th1 and Th2-like cytokine production is significantly
inhibited by cAMP elevating agents in freshly isolated T cells. T
lymphocytes were isolated from healthy donors and rested over-
night. PGE2 and fenoterol were added in a concentration of 10 mM
and cells were subsequently stimulated with a-CD3/a-CD28 for 8 h.
IFN-g, IL-4 and IL-5 protein secretion were measured in cell-free
supernatants. Protein levels are expressed as percentage (x7s.e.m.,
n¼ 8) of the secretion after stimulation with a-CD3/a-CD28 in the
absence of cAMP elevating agents. *Po0.05 and **Po0.001 for the
cytokine secretion levels after preincubation with cAMP elevating
agents compared to the level without these agents. (b) Dose –
response curves for PGE2 and fenoterol on the secretion of IFN-g
and IL-5. Freshly isolated T cells were incubated with different
concentrations of PGE2 or fenoterol and subsequently stimulated
with a-CD3/a-CD28 for 8 h. IFN-g, IL-4 and IL-5 protein secretions
were measured in cell-free supernatants. Protein levels are expressed
as percentage (x7s.e.m., n¼ 4) of the secretion after stimulation
with a-CD3/a-CD28 in absence of cAMP elevating agents. (c)
Cytokine production in polarized Th1 and Th2 cells is not under
strict control of cAMP elevating agents. Polarized Th1 and Th2 cells
were rested overnight in RPMI medium containing 5% FCS and
stimulated for 6 h with a-CD3/a-CD28. PGE2 and fenoterol were
added prior to stimulation, in a concentration of 10 mM. IFN-g, IL-4
and IL-5 proteins were measured in supernatants. Protein levels are
expressed as percentage (x7s.e.m., n¼ 8) of the secretion after
stimulation with a-CD3/a-CD28 in the absence of cAMP elevating
agents. *Po0.05 for the cytokine secretion levels after preincubation
with cAMP elevating agents compared to the level without these
agents.
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freshly isolated T cells, both PGE2 and fenoterol (10 mM)
clearly induced CREB phosphorylation (Figure 2), the effect
of PGE2 being most pronounced. In contrast, in Th1 cells, no
phosphorylation of CREB could be observed upon stimulation
with PGE2 and fenoterol. These results suggest that the
defective regulation of cytokine production by fenoterol and
PGE2 in Th1 cells is because of impaired activation of the
cAMP downstream pathway. In Th2 cells, PGE2 was able to
induce a clear increase in CREB phosphorylation, whereas
fenoterol only slightly enhanced the levels of phosphorylated
CREB. Thus, the ability of PGE2 to activate the cAMP-
dependent pathway is impaired in Th1 cells and still intact in
Th2 cells, whereas b2-adrenergic activation of this pathway
appears to be disturbed in both Th1 and Th2 cells. To study if
this b2-adrenergic hyporesponsiveness in polarized cells is a
consequence of the proliferation and activation induced by
culturing under polarizing conditions, we studied the effect of
neutral (Th0) conditions, that is, PHA, IL-2 and irradiated
APC. In T cells cultured under these conditions for 7 days,
fenoterol was not able to induce phosphorylation of CREB
either. In contrast, PGE2 could still enhance CREB phosphor-
ylation. These data suggest that b2-adrenergic hyporespon-
siveness may develop by polyclonal activation of T cells during
polarization.
Impaired formation of intracellular cAMP by PGE2 in
Th1 cells
To study in more detail the defects of PGE2 and b2-receptor
function, we measured the capacity of these agents to enhance
the accumulation of intracellular cAMP in freshly isolated and
polarized T cells. To prevent degradation of cAMP during the
assay, cells were incubated with PDE inhibitor IBMX.
Addition of IBMX strongly enhanced accumulation of
intracellular cAMP in both polarized and freshly isolated T
cells: from 0.3270.06 to 2.0970.58 pmol cAMP in Th1 cells,
from 0.1870.07 to 1.8371.0 pmol cAMP in Th2 cells and
from 0.2270.09 to 1.9370.58 pmol cAMP in freshly isolated
T cells (Figure 3a). In both Th1 and Th2 cells, fenoterol was
unable to increase intracellular cAMP levels (data not shown).
Addition of PGE2 (10mM) induced a significant increase in
cAMP production in both freshly isolated T cells and polarized
Th2 cells (fold increase 263771 and 208749%, Po0.05 and
Po0.01, respectively), but not in Th1 cells (110741%,
Figure 3b). Thus, these data show a difference in PGE2
functionality in Th1 cells versus Th2 and freshly isolated T
cells. Together, our findings suggest that the defective
regulation of cytokine production by cAMP elevating in
polarized T helper is caused by the inability of PGE2 receptor
and/or b2-AR stimulation to increase intracellular cAMP
levels.
As previously described, one of the mechanisms responsible
for the impaired capacity to increase cAMP accumulation may
be the upregulation of cAMP-specific PDE’s (Seybold et al.,
1998), which are responsible for the degradation of cAMP.
However, basal levels of cAMP were not reduced in polarized
T helper cells compared to freshly isolated T cells, indirectly
indicating that basal activity of PDE’s is not enhanced.
Additionally, the responsiveness of cytokine production to
PDE inhibitors was not enhanced in polarized T cells
compared to freshly isolated T cells (data not shown). Thus,
Figure 2 CREB phosphorylation in the presence of fenoterol and
PGE2 in freshly isolated T cells and T cells polarized under Th1, Th2
and Th0 conditions. T cells were stimulated with 10 mM PGE2 or
10 mM fenoterol for 60min. Total cell lysates were prepared and
phosphorylated CREB was detected by Western blotting. Phospho-
CREB is depicted in the upper panel and total protein levels (actin)
are shown in the lower panel (marked by arrows). The correspond-
ing diagram shows the relative phospho-CREB values after
normalisation for actin. Results shown are representative of three
independent experiments.
Figure 3 (a) Incubation with IMBX strongly enhances cAMP
accumulation in Th1, Th2 and freshly isolated T cells. Basal
intracellular cAMP accumulation (fmol) and cAMP accumulation in
the presence of IBMX (100 mM) was measured in freshly isolated T
cells and polarized Th1 and Th2 cells. Values are presented as the
means7s.e.m. of four independent experiments. *Po0.001 for the
values with IBMX compared to the values without IBMX. (b) PGE2
enhances cAMP formation in freshly isolated T cells and polarized
Th2 cells, but not in polarized Th1 cells. cAMP accumulation was
induced by PGE2 (10 mM) in the presence of IBMX and measured in
freshly isolated T cells and Th1 and Th2 cells. cAMP levels are
expressed as percentage (x7s.e.m., n¼ 4) of the formation in
absence of PGE2.
*Po0.05 for the values with PGE2 compared to
the values without PGE2.
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PDE’s are unlikely to play a role in the reduced responsiveness
to cAMP elevating substances.
CREB phosphorylation is induced and cytokine produc-
tion is strongly inhibited by db-cAMP, IBMX and direct
stimulation of the Gs protein in polarized Th1 and Th2
cells
Next, it was of interest to study whether cAMP is still able to
activate its downstream pathway and to negatively regulate
cytokine production in polarized T helper cells. As demon-
strated in Figure 4a, strong induction of CREB phosphoryla-
tion was observed when db-cAMP was added to Th1 cells.
These results clearly demonstrate that cAMP-induced signal-
ing is not impaired in these cells. Moreover, addition of IBMX
increased both cAMP accumulation (see the results described
above) and CREB phosphorylation in Th1 cells, indicating
that intracellular cAMP generation is not disturbed. Finally,
direct activation of the AC-coupled Gs protein by NaF
resulted in strong induction of CREB phosphorylation. This
indicates that the defective induction of CREB phosphoryla-
tion by PGE2 and fenoterol is most likely caused at receptor
level. Similar results with db-cAMP, IBMX and NaF were
observed in Th2 cells (Figure 4a) and freshly isolated T cells
(data not shown).
In addition, we examined whether IBMX or db-cAMP could
also inhibit IFN-g and IL-5 protein secretion in Th1 and Th2
cells, respectively. Indeed, enhancement of intracellular levels
of cAMP by the addition of IBMX reduced a-CD3/a-CD28
stimulated IL-5 and IFN-g protein secretion by approximately
85%. Similar results were obtained with cAMP analog db-
cAMP (Figure 4b). These data demonstrate that cytokine
production can still be efficiently regulated by the cAMP-
dependent pathway in polarized T helper cells, supporting the
findings that the reduced responsiveness to PGE2 and/or b2-
agonist fenoterol in polarized Th cells is because of impaired
activation of the AC system and not differential regulation of
cytokine production.
Enhanced expression of bARK (GRK3) in polarized T
helper cells
We were interested in the possible mechanisms involved in the
desensitization of the PGE2 and/or fenoterol effects in
polarized Th1 and Th2 cells. Desensitization of the b2-AR
can be induced by either downregulation of mRNA and
protein levels of the receptor (Rademaker et al., 1990) or by
phosphorylation of the receptor, which results in functional
uncoupling from the Gs protein and internalization of the
receptor. First, the expression level of mRNA was determined
using RT – PCR. We observed that, similar to freshly isolated
T cells, b2AR mRNA was clearly expressed in both Th1 and
Th2 subsets (Figure 5a). Thus, downregulation of b2AR
mRNA is not likely the cause of desensitization of the b2-
adrenergic system in Th1 and Th2 cells. GRK’s, as well as
PKA and protein kinase C (PKC) are able to phosphorylate
the b2-AR (Meurs et al., 1987; Hausdorff et al., 1990).
Enhanced expression and activation of bARK are known to
induce b2-AR desensitization because of enhanced and more
rapid phosphorylation of the receptor (Lohse et al., 1992;
McGraw & Liggett, 1997; Penn et al., 1998). It has been
described that treatment of T cells with polyclonal activators
(PHA, a-CD3 and IL-2) for 3 – 7 days results in enhanced
bARK (GRK3) and GRK6 mRNA and protein levels as well
as increased activity of both kinases (Loudon et al., 1996).
Therefore, we analyzed the levels of bARK2/GRK3 in
polarized Th cells and freshly isolated T cells by immunoblot-
ting. As demonstrated in Figure 5b, the expression of bARK
was dramatically enhanced in polarized Th1 cells compared to
freshly isolated T cells. The expression in Th2 cells was lower,
but still strongly enhanced compared to freshly isolated T cells.
In addition, we studied the expression of bARK in T cells
cultured under neutral conditions, which also showed defective
induction of CREB phosphorylation by fenoterol. In these
cells, levels of bARK were strongly enhanced compared to
freshly isolated T cells as well. Thus, polyclonal activation of T
Figure 4 (a) CREB phosphorylation is induced by cAMP elevating
agents in polarized Th1 and Th2 cells. T cell subsets were stimulated
with db-cAMP, IBMX or NaF for 60min. Total cell lysates were
prepared and phosphorylated CREB was detected by Western
blotting. Phospho-CREB is depicted in the upper panel and total
protein levels (actin) are shown in the lower panel (marked by
arrows). Results shown are representative of three independent
experiments. (b) Cytokine production in polarized Th1 and Th2 cells
is under strict control of potent activators of the cAMP-dependent
pathway. Polarized Th1 and Th2 cells were cultured overnight in
RPMI medium containing 5% FCS and stimulated for 6 h with a-
CD3/a-CD28. IBMX or db-cAMP was added prior to stimulation,
in a concentration of 100mM, 0.5 and 10mM respectively. IFN-g and
IL-5 protein secretions were measured in cell-free supernatants.
Protein levels are expressed as percentage (x7s.e.m., n¼ 3) of the
secretion after stimulation with a-CD3/a-CD28 in the absence of
cAMP elevating agents. *Po0.05 for the cytokine secretion level
after preincubation with cAMP elevating agents compared to the
level without these agents.
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cells during polarization might induce an increase in bARK
expression, which in turn might be involved in the loss of
b2-adrenergic control.
Altered levels of PGE2 receptor subtypes in polarized T
helper cells
In addition to b2-adrenergic unresponsiveness, polarized
Th1 were unresponsive to PGE2. Although, the mechanism
of b2AR desensitization has been widely described, little
information is available about desensitization and internaliza-
tion of the PGE2 receptor. It is known that PGE2 can
exert differential effects through activation of different
subtypes of the receptor. At least four different subtypes are
known, that is, the EP1, EP2, EP3 and EP4 subtypes. It has been
described that EP4 is susceptible to agonist-promoted
internalization, whereas the EP2 receptor is resistant. EP2
and EP4 are known to be coupled to the Gs protein and induce
AC activation. On the other hand, activation of EP1 induces
Ca2+ accumulation, while the EP3 subtype preferentially
couples to Gi, thereby inhibiting cAMP generation (An et al.,
1993; Funk et al., 1993; Yang et al., 1994; Breyer & Breyer,
2001; Castleberry et al., 2001). To study if differential
expression of the PGE2 receptor could be involved in the
altered PGE2 signaling in polarized T helper cells, we measured
the mRNA expression of the Gs-coupled EP2 subtype and the
Gi-coupled EP3 subtype of the PGE2 receptor using RT – PCR.
As demonstrated in Figure 6, the expression of EP2
was reduced in both Th1 and Th2 cells compared to freshly
isolated T cells. This may be involved in the reduced
responsiveness of cytokine production to PGE2 that was
observed in both Th1 and Th2 cells compared to freshly
isolated T cells; yet, this does not explain the difference of
PGE2 reactivity in Th1 and Th2 cells. As described above,
PGE2 was able to activate the AC/cAMP-dependent pathway
in Th2 cells, while this was not the case in Th1 cells. In contrast
to the Gs-coupled EP2, subtype, the expression of the
Gi-coupled EP3 subtype appeared to be about a two-fold
higher in Th1 cells compared to freshly isolated T cells as well
as Th2 cells (Figure 6). Since activation of the Gs protein is
known to result in activation of the AC/cAMP system, while
activation of the Gi protein is known to inhibit this system, the
altered ratio in EP2 and EP3 expression in Th1 cells might be
an explanation for the net zero effect of PGE2 on cAMP
production in Th1 cells (see Figure 3b). Thus, differential
expression of subtypes of the PGE2 receptor might be involved
in the unresponsiveness of Th1 cells to PGE2.
Discussion
Specialized Th1 and Th2 subsets direct immune responses at
sites of inflammation by the production of a defined pattern of
cytokines. An important regulator of proinflammatory activity
is the cAMP-dependent pathway. At sites of tissue inflamma-
Figure 5 (a) b2AR mRNA is clearly expressed in Th1 and Th2
cells. RNA was isolated from polarized Th1 and Th2 cells and total
cellular RNA was analyzed by RT – PCR. In the upper panel, the
b2AR signal is shown. The b2mG signal in the lower panel shows that
comparable amounts of product were amplified for each condition.
Results shown are representative of two independent experiments.
(b) Expression of bARK is strongly enhanced in polarized Th1, Th2
and Th0 cells compared to freshly isolated T cells (n¼ 3). Expression
of bARK in polarized Th1 and Th2 cells was analyzed by Western
blotting. bARK is depicted in the upper panel and actin is depicted
in the lower panel. A representative blot is shown. The bARK levels
in Th1, Th2, Th0 and freshly isolated T cells were normalized for
actin and mean relative bARK values7s.e.m. of four different
experiments are depicted in the corresponding diagram.
Figure 6 Altered expression of the EP2 and EP3 subtypes of the
PGE2 receptor in Th1 and Th2 cells compared to freshly isolated T
cells. RNA was isolated from polarized Th1 and Th2 cells and total
cellular RNA was analyzed by RT – PCR. In the upper panel, the
EP2 signal shows reduced expression in Th1 and Th2 cells compared
to freshly isolated T cells. In the middle panel, the EP3 signal shows
enhanced expression in Th1 cells compared to Th2 cells and freshly
isolated T cells. The b2mG signal is depicted in the lower panel. The
corresponding diagram shows the relative EP2 and EP3 mRNA
values after normalization for b2mG. Results shown are representa-
tive of three independent experiments.
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tion, T cells have ample opportunity to encounter cells that
produce cAMP elevating agents, for example, PGE2. The
regulatory effects of cAMP have been widely studied in freshly
isolated T cells and in T-cell clones, but not in specialized T
helper subset cells, which can be obtained by in vitro
differentiation under Th1 or Th2 polarizing conditions. In
the present report, we demonstrate that cytokine secretion in
polarized T helper cells is not strictly controlled by cAMP
elevating agents. Although the a-CD3/a-CD28 stimulation
method cannot necessarily be extrapolated to the activation of
T cells by antigen, our results may have important implications
for the regulation of Th1- and Th2-mediated immune
responses. Our findings are in contrast to the results in freshly
isolated T cells, where the production of the Th1-like cytokine
IFN-g was almost fully blocked by cAMP elevating substances
and significant inhibition of Th2-like cytokine (IL-4, IL-5)
production was observed. The inhibitory effect on IFN-g
secretion appeared to be completely abolished in polarized Th1
cells, while the inhibitory effect on IL-4 and IL-5 in polarized
Th2 cells was reduced compared to freshly isolated T cells.
Thus, whereas in freshly isolated T cells, Th1 cytokine
production is more susceptible to cAMP inhibition than Th2
cytokine production, polarized Th2 cells appear to be more
sensitive to PGE2 than polarized Th1 cells. PGE2 was able to
induce an increase in cAMP production and CREB phosphor-
ylation in Th2 cells, while PGE2 was unable to enhance cAMP
production and subsequently activate downstream signals in
Th1 cells. This may have implications for the Th1/Th2 balance
at sites of tissue inflammation, where specialized Th1 or Th2
subsets may be found. Our data indicate that the loss of PGE2
control over IFN-g production in polarized Th1 cells is most
likely because of a defect at receptor level and is not caused by
differential regulation of cytokine production. This is sup-
ported by the finding that preincubation with db-cAMP,
IBMX or NaF significantly enhances CREB phosphorylation
and strongly inhibits IFN-g production, indicating that IFN-g
production is still under the control of the cAMP-dependent
pathway. Defective induction of CREB phosphorylation might
indeed lead to a loss of control over IFN-g production, since it
has been shown that CREB inhibits Jun-mediated activation
of the IFN-g promoter by competitive binding (Zhang et al.,
1998). In addition to the regulation of cytokine production, the
cAMP-dependent pathway has been described to induce
apoptosis in T lymphocytes (Gu et al., 2000). Thus, our results
might also have implications for the survival of Th1 and Th2
subsets in inflamed tissue, where T cells have opportunity to
encounter PGE2 secreting cells.
In contrast to the differential effects of PGE2 in Th1 and
Th2 subsets, we found reduced responsiveness to the b2-
agonist fenoterol in both Th1 and Th2 cells. This seems to be
because of a defect at receptor level, since the ability of
fenoterol to activate the cAMP-dependent pathway was
impaired in polarized T cells. If the in vitro polarized T cells
are indeed representative for specialized Th1 and Th2 subsets
in vivo, our results suggest that the use of b2-mimetics, for
instance in asthma, may not efficiently inhibit proinflamma-
tory T-cell activity. Several mechanisms may be responsible for
the desensitization of the b2-AR. First, prolonged agonist
binding can result in downregulation of the total cellular levels
of the receptor (both mRNA and protein) and contribute to
desensitization of the receptors (Rademaker et al., 1990).
However, no indications for a prolonged repression of receptor
gene transcription, resulting in decreased receptor expression,
were observed in polarized Th cells; mRNA for the b2AR was
clearly expressed in polarized Th1 cells and Th2 cells. Thus, a
functional uncoupling of the b2AR and PGE2 receptor from
the Gs protein seems to be more likely. This can be caused by
phosphorylation of the receptor by GRKs, PKA or PKC
(Meurs et al., 1987; Hausdorff et al., 1990). Phosphorylation of
the active form of the receptor by bARK (also GRK3)
promotes binding of b-arrestin to the receptor, resulting in
uncoupling from the Gs protein and finally internalization of
the receptor (Gu et al., 2000). Enhanced expression and
activation of bARK may induce b2-adrenergic hyporespon-
siveness (Lohse et al., 1992). It has been demonstrated that
overexpression of bARK leads to hyporesponsiveness of the
b2-AR because of enhanced and more rapid agonist-induced
phosphorylation of the receptor (McGraw & Liggett, 1997;
Penn et al., 1998). Indeed, we found that bARK levels in
polarized Th1 and Th2 cells were strongly enhanced compared
to freshly isolated T cells. In addition, high levels of bARK
were observed in T cells polarized under neutral (Th0)
conditions, where reduced responsiveness to b2-agonist feno-
terol was also found. These data suggest that polyclonal
activation of T cells during polarization induces upregulation
of bARK, thereby reducing the responsiveness to b2-agonists.
In this way, T cells may become less sensitive to circulating b2-
agonists (e.g. epinephrine) during the induction of cell cycle
progression at the initiation of immune responses.
So far, little information is available on the regulation of the
PGE2 receptor. It has been demonstrated that the EP4 subtype
of the PGE2 receptor is susceptible to agonist-promoted
internalization, whereas the EP2 subtype receptor is resistant
(Penn et al., 2001). EP4 desensitization can occur by a similar
mechanism as b2-adrenergic desensitization, involving bARK
and b-arrestin. Therefore, a role for enhanced bARK
expression in PGE2 unresponsiveness in Th1 cells cannot be
excluded, although it is not clear why Th2 cells, expressing
high levels of bARK, were still responsive to PGE2. We show
that another possible mechanism involved in reduced respon-
siveness to PGE2 might be the altered balance in EP2/EP3
mRNA expression. EP2 mRNA was reduced in both Th1 and
Th2 subsets compared to freshly isolated T cells, whereas EP3
mRNA expression was only enhanced in Th1 cells. Thus, the
reduced expression of EP2 could explain why Th2 cells are less
responsive to PGE2 than freshly isolated T cells, while the
additional upregulation of mRNA for the Gi-coupled EP3
receptor in Th1 cells may be responsible for the complete
unresponsiveness to PGE2 in these cells. It is known that
activation of the Gi protein by PGE2 and b2-agonists does not
result in cAMP formation, but instead causes activation of the
PI3-kinase-dependent antiapoptotic pathways (Zhu et al.,
2001). Our data suggest that coupling of the PGE2 receptors
to the Gi protein is enhanced in polarized Th1 cells compared
to freshly isolated T cells. This might result in a net zero effect
on cAMP production and activation of downstream pathways,
since activation of Gi counteracts the effects induced by
activation of the Gs protein. It still remains unclear as to what
causes the Th1 specific upregulation of EP3 mRNA. Incuba-
tion of T cells with the Th1-directing cytokine IL-12 alone for
prolonged periods did not result in reduced ability of PGE2 to
activate the cAMP-dependent pathway (data not shown).
Possibly, entering the cell cycle and epigenetic remodeling
during Th1 polarization are required to induce upregulation of
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EP3 expression. Another G-coupled receptor that can trigger
different intracellular events through different receptor sub-
types is the histamine receptor. It has been demonstrated that
histamine reduces cytokine (IL-4, IL-13) production and
elevates cAMP production in differentiated murine Th2 cells,
which preferentially expressed the histamine receptor type 2
(HR2) (Jutel et al., 2001). In contrast, Th1 cells preferentially
expressed HR1, leading to an increase in calcium influx instead
of an increase in intracellular cAMP levels upon activation and
in addition an upregulation of IFN-g production (Jutel et al.,
2001). Thus, reduced linking of G protein-coupled receptors to
the AC system seems to be a general phenomenon in polarized
Th1 cells. Together, our findings suggest that resting T cells in
peripheral blood are under strict control of Gs protein-coupled
receptors, while this control is lost when T cells become
activated at the sites of tissue inflammation and differentiate
into effector T cells. The loss of control may allow appropriate
activation and increase the survival of effector Th cells. Th1
cells appear to be less responsive to G protein-coupled
receptors than Th2 cells, favoring activation of the Th1
subtype.
In summary, our study demonstrates that polarized T helper
cells are less responsive to PGE2 and the b2-agonist fenoterol
than circulating T cells. This lack of negative feedback control
may have implications for ongoing inflammatory processes,
since cytokine production in effector Th2 cells may not be
efficiently suppressed and the activity of Th1 cells may not be
suppressed at all by a b2-agonist or PGE2 secreted by
surrounding tissue cells.
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